BASF expands MDI capacity at Verbund site in Geismar
Chemical

BASF expands MDI capacity at Verbund site in Geismar

This final phase of the expansion project, which includes several new upstream units, is targeted to be complete by the middle of the decade, with resulting total MDI capacity of approximately 600,000 m.t./yr

  • By ICN Bureau | December 15, 2021
BASF SE has announced that the implementation of the methylene diphenyl diisocyanate (MDI) capacity increase program for BASF’s Verbund site in Geismar, Louisiana, is progressing on schedule. Over time, BASF plans to double the capacity from 300,000 metric tons per year (m.t./yr) to approximately 600,000 m.t./yr.
 
“This investment in the attractive North American MDI market strengthens our position as a leading MDI supplier in North America as well as globally,” said Dr. Ramkumar Dhruva, President of Monomers Division.
 
“The Geismar site is ideally suited for this investment thanks to its existing infrastructure, competitive raw materials and ongoing strong business support from state and local government,” said Stefan Doerr, Senior Vice President, Monomers North America. “With this integrated facility, BASF will continue to support the growth of our North American MDI customers.”
 
The first phase involving the construction of a new MDI synthesis unit has been in operation since October of last year. The second phase, which started up recently, expanded several existing upstream units and increased the overall MDI output of the Geismar complex by approximately one third. Engineering for the final phase of the MDI expansion is progressing on schedule. This final phase of the expansion project, which includes several new upstream units, is targeted to be complete by the middle of the decade, with resulting total MDI capacity of approximately 600,000 m.t./yr.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.